Search

everythinglearnresearchcommunity

for

Search:↓

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

The conclusion is that a new biopsy technique and humidity chamber help study skin mites better and suggest mite overpopulation may cause skin diseases.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Fungal infections in lab animals can interfere with research.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Calcium microcapsules are better for long-term use in artificial dermal papilla, while barium microcapsules are good for short-term.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

Xeno-free three-dimensional stem cell masses are safe and effective for improving blood flow and tissue repair in limb ischemia.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.